Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT00004364 |
Other study ID # |
199/11939 |
Secondary ID |
NU-570 |
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
October 18, 1999 |
Last updated |
February 21, 2006 |
Start date |
December 1995 |
Study information
Verified date |
February 2006 |
Source |
Office of Rare Diseases (ORD) |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
United States: Federal Government |
Study type |
Observational
|
Clinical Trial Summary
OBJECTIVES:
I. Define the phenotype and genotype of previously unrecognized types of familial diabetes
insipidus (FDI) in kindreds with atypical or novel forms of FDI.
Description:
PROTOCOL OUTLINE: Participants undergo a series of tests to determine the presence, absence,
cause, natural history, clinical status, and mode of inheritance of their type of diabetes
insipidus (DI). The studies include measurements of basal fluid intake and urine output,
plasma vasopressin during standard fluid deprivation or waterload/saline infusion tests, and
changes in water balance during a therapeutic trial of DDAVP. If clinically indicated,
echocardiograms and assays of plasma catecholes and renin are also completed.
Linkage analysis is performed for all participants; kindreds with the Marfan-like syndrome
are also studied for the fibrillin-1 genotype.
Participants determined to have DI are treated with desmopressin for 2 days.